Zylö Therapeutics Closes $4 Million Series A Financing

Zylö Therapeutics Closes $4 Million Series A Financing

Zylö Therapeutics Inc., dedicated to developing a transformational topical delivery platform, announced that on September 21, 2019, it effected a closing of its Series A financing through the sale of $4 million of Series A preferred shares. Read more >>

Share this post